Last edition
News about " Sirolimus-Coated Balloon Strategy"
TRANSFORM 2 Trial Shows Sirolimus-Coated Balloon Matches Drug-Eluting Stents
TRANSFORM 2 trial found Concept Medical’s MagicTouch sirolimus-coated balloon non-inferior to drug-eluting stents, demonstrating comparable 12-month outcomes in 1,842 patients with coronary artery disease.
Sirolimus-Coated Balloon Strategy | 06/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members